Overview
Frontometaphyseal dysplasia (FMD) is a rare skeletal disorder belonging to the group of otopalatodigital spectrum disorders. It is characterized by prominent supraorbital ridges (frontal bossing), which give the face a distinctive appearance, combined with abnormal modeling (metaphyseal dysplasia) of the long bones. The condition affects multiple body systems including the skeletal, craniofacial, auditory, and respiratory systems. Key craniofacial features include a prominent brow ridge, wide nasal bridge, small mandible (micrognathia), and dental anomalies. Skeletal manifestations include bowing of the long bones, joint contractures (particularly of the fingers and toes), scoliosis, and metaphyseal flaring. Conductive hearing loss is common due to abnormalities of the ossicles in the middle ear. Some patients may develop subglottic stenosis (narrowing of the airway below the vocal cords), which can be a serious and potentially life-threatening complication. Frontometaphyseal dysplasia is most commonly caused by gain-of-function mutations in the FLNA gene (filamin A), located on the X chromosome. A second form (FMD type 2) has been associated with mutations in the MAP3K7 gene, inherited in an autosomal dominant pattern. Males with FLNA-related FMD tend to be more severely affected than females, who may show milder or variable features. The condition is typically recognized in childhood based on the characteristic facial features and skeletal abnormalities, with radiographic findings confirming the diagnosis. There is currently no cure for frontometaphyseal dysplasia. Treatment is supportive and multidisciplinary, focusing on managing specific symptoms. This may include hearing aids for conductive hearing loss, orthopedic interventions for skeletal deformities and joint contractures, dental care, and surgical management of airway obstruction when subglottic stenosis is present. Regular monitoring by specialists in genetics, orthopedics, otolaryngology, and audiology is recommended to address complications as they arise.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Frontometaphyseal dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Frontometaphyseal dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Frontometaphyseal dysplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Frontometaphyseal dysplasia.
Community
No community posts yet. Be the first to share your experience with Frontometaphyseal dysplasia.
Start the conversation →Latest news about Frontometaphyseal dysplasia
No recent news articles for Frontometaphyseal dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Frontometaphyseal dysplasia
What is Frontometaphyseal dysplasia?
Frontometaphyseal dysplasia (FMD) is a rare skeletal disorder belonging to the group of otopalatodigital spectrum disorders. It is characterized by prominent supraorbital ridges (frontal bossing), which give the face a distinctive appearance, combined with abnormal modeling (metaphyseal dysplasia) of the long bones. The condition affects multiple body systems including the skeletal, craniofacial, auditory, and respiratory systems. Key craniofacial features include a prominent brow ridge, wide nasal bridge, small mandible (micrognathia), and dental anomalies. Skeletal manifestations include bow
At what age does Frontometaphyseal dysplasia typically begin?
Typical onset of Frontometaphyseal dysplasia is childhood. Age of onset can vary across affected individuals.